» Articles » PMID: 22808300

Giant Cell Ependymoma-report of Three Cases and Review of the Literature

Overview
Specialty Pathology
Date 2012 Jul 19
PMID 22808300
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ependymomas constitute the most common type of primary spinal cord tumors, and are subclassified as myxopapillary ependymoma, classic ependymoma, and anaplastic ependymoma. Ependymomas can be further subclassified based on morphologic phenotype: cellular, papillary, tanycytic, clear cell, pigmented and epithelioid. Giant cell ependymoma (GCE), a rare variant, has recently been described. Reported cases have exhibited a wide anatomic distribution, including spinal cord, cerebrum and cerebellum. We report here three cases of GCE, arising from cerebrum in a 5-year-old girl, spinal cord in a 34-year-old female and cerebellum in an 86-year-old female respectively. Histologically those cases showed prominent pleomorphic giant cells with focal perivascular pseudorosettes in all cases. Tumor cells were immunopositive for GFAP and EMA. Only the first case was qualified for anaplastic ependymoma. No recurrence was noted in these three cases after 57, 46 and 6 months of follow-up respectively. By reviewing the literature, GCEs arising from spinal cord and cerebellum tended to have low-grade morphology while supratentorially located GCEs tended to have anaplastic features. GCEs were preferentially located in extraventricular regions. Anaplastic GCEs in adult population seemed to pursue a more aggressive behavior. Gross total resection should still be the main treatment for GCEs.

Citing Articles

Ventricular system-unrelated cerebellar ependymoma: A case report.

Yang C, Xue R, Yang L, Jieda X, Xiang W, Zhou J World J Clin Cases. 2024; 12(25):5814-5820.

PMID: 39247726 PMC: 11263058. DOI: 10.12998/wjcc.v12.i25.5814.


Factors associated with postoperative outcomes in patients with intramedullary Grade II ependymomas: A Systematic review and meta-analysis.

Sun X, Wang W, Zhang T, Kong C, Sun S, Guo M Medicine (Baltimore). 2019; 98(25):e16185.

PMID: 31232977 PMC: 6637017. DOI: 10.1097/MD.0000000000016185.


Outcome predictors in the management of intramedullary classic ependymoma: An integrative survival analysis.

Wang Y, Cai R, Wang R, Wang C, Chen C Medicine (Baltimore). 2018; 97(23):e10870.

PMID: 29879023 PMC: 5999504. DOI: 10.1097/MD.0000000000010870.


Intraoperative squash cytology and histology of giant cell ependymoma: A diagnostic dilemma.

Cakir E, Kucuk U, Ersen A, Pala E, Senoglu M, Binatli A J Cytol. 2017; 34(1):63-65.

PMID: 28182061 PMC: 5259938. DOI: 10.4103/0970-9371.197625.


Immunohistochemical features of giant cell ependymoma of the filum terminale with unusual clinical and radiological presentation.

Candanedo-Gonzalez F, Ortiz-Arce C, Rosales-Perez S, Remirez-Castellanos A, Cordova-Uscanga C, Gamboa-Dominguez A Diagn Pathol. 2017; 12(1):7.

PMID: 28088216 PMC: 5237534. DOI: 10.1186/s13000-016-0595-y.


References
1.
Fourney D, Siadati A, Bruner J, Ziya L Gokaslan , Rhines L . Giant cell ependymoma of the spinal cord. Case report and review of the literature. J Neurosurg. 2004; 100(1 Suppl Spine):75-9. DOI: 10.3171/spi.2004.100.1.0075. View

2.
Szpak G, Lewandowska E, Schmidt-Sidor B, Pasennik E, Modzelewska J, Stepien T . Giant cell ependymoma of the spinal cord and fourth ventricle coexisting with syringomyelia. Folia Neuropathol. 2008; 46(3):220-31. View

3.
Adamek D, Dec M, Sobol G, Urbanowicz B, Jaworski M . Giant cell ependymoma: a case report. Clin Neurol Neurosurg. 2007; 110(2):176-81. DOI: 10.1016/j.clineuro.2007.09.018. View

4.
Shamji M, Benoit B, Perry A, Jansen G . Giant cell ependymoma of the thoracic spine: pathology case report. Neurosurgery. 2009; 64(3):E566-7. DOI: 10.1227/01.NEU.0000338428.01654.A4. View

5.
Zec N, De Girolami U, Schofield D, Scott R, Anthony D . Giant cell ependymoma of the filum terminale. A report of two cases. Am J Surg Pathol. 1996; 20(9):1091-101. DOI: 10.1097/00000478-199609000-00007. View